Nirsevimab Beyfortus: Most of you have probably heard a lot of buzz surrounding the Nirsevimab Beyfortus immunization to protect newborns and babies under 8 months of age from developing severe disease related to RSV or Respiratory Syncytial Virus. Nirsevimab works to protect newborns and infants from RSV because it is designed with long-acting monoclonal antibodies.

Every year, an estimated 33.1 million children under five years of age suffer from an acute lower respiratory tract infection, with the majority of these illnesses caused by RSV. This leads to approximately 3.2 million child hospitalizations and around 100,000 deaths annually due to RSV infection. Nirsevimab does not protect anyone from acquiring RSV, but it significantly reduces the risk of hospitalization or needing medical treatment. Studies have shown that Nirsevimab administration reduces the risk of needing to seek medical care related to lower respiratory symptoms by 83%.

We have kept our youngest patients waiting long enough for this protection, and now it’s here! Please call 763-333-7733 to schedule an appointment!

Flu and COVID Vaccines are available, please call to schedule an appointment! For vaccine Nurse-only visits, CTMC has the following policies:

• Child must be at least 6 months old
• Must be up to date on well-child exams
• If your child has asthma, they need to be up to date on Asthma Medication Reviews